These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36280470)

  • 1. Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
    Zierfuss B; Höbaus C; Feldscher A; Hannes A; Mrak D; Koppensteiner R; Stangl H; Schernthaner GH
    Atherosclerosis; 2022 Dec; 363():94-101. PubMed ID: 36280470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease.
    Golledge J; Rowbotham S; Velu R; Quigley F; Jenkins J; Bourke M; Bourke B; Thanigaimani S; Chan DC; Watts GF
    J Am Heart Assoc; 2020 Mar; 9(6):e015355. PubMed ID: 32172653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated lipoprotein (a) levels and risk of peripheral artery disease outcomes: A systematic review.
    Masson W; Lobo M; Barbagelata L; Molinero G; Bluro I; Nogueira JP
    Vasc Med; 2022 Aug; 27(4):385-391. PubMed ID: 35466849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of High Lipoprotein(a) Levels on Clinical Outcomes Following Peripheral Endovascular Therapy.
    Tomoi Y; Takahara M; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
    JACC Cardiovasc Interv; 2022 Jul; 15(14):1466-1476. PubMed ID: 35863797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
    Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients.
    Yi C; Junyi G; Fengju L; Qing Z; Jie C
    Clin Cardiol; 2023 May; 46(5):512-520. PubMed ID: 36896666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Density Lipoprotein Particle Subclasses in Statin-Treated Patients with Peripheral Artery Disease Predict Long-Term Survival.
    Zierfuss B; Höbaus C; Herz CT; Koppensteiner R; Stangl H; Schernthaner GH
    Thromb Haemost; 2022 Oct; 122(10):1804-1813. PubMed ID: 35436798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy.
    Verwer MC; Waissi F; Mekke JM; Dekker M; Stroes ESG; de Borst GJ; Kroon J; Hazenberg CEVB; de Kleijn DPV
    Atherosclerosis; 2022 May; 349():196-203. PubMed ID: 34857353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype.
    Zierfuss B; Feldscher A; Höbaus C; Hannes A; Koppensteiner R; Schernthaner GH
    Sci Rep; 2023 May; 13(1):8029. PubMed ID: 37198240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E; Gomez-Rodriguez V; Orbe J; Rodriguez JA; Fernández-Alonso L; Roncal C; Páramo JA
    J Vasc Surg; 2015 Feb; 61(2):428-35. PubMed ID: 25441671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences Between Patients With Intermittent Claudication and Critical Limb Ischemia Undergoing Endovascular Intervention: Insights From the Excellence in Peripheral Artery Disease Registry.
    Patel K; Liu Y; Etaee F; Patel C; Monteleone P; Patel M; Amer Alaiti M; Metzger C; Banerjee A; Minniefield N; Tejani I; Brilakis ES; Shishehbor MH; Banerjee S
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e010635. PubMed ID: 34706553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD.
    Hogan SE; Nehler MR; Anand S; Patel MR; Debus S; Jackson MT; Buchanan C; King RW; Hess C; Muehlhofer E; Haskell LP; Bauersachs RM; Berkowitz SD; Hsia J; Bonaca MP
    Vasc Med; 2022 Aug; 27(4):343-349. PubMed ID: 35467452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
    Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
    Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Endovascular Treatment of Isolated Atherosclerotic Popliteal Artery Disease: Outcomes from the IPAD Multicenter Study.
    Spiliopoulos S; Kitrou P; Galanakis N; Papadimatos P; Katsanos K; Konstantos C; Palialexis K; Reppas L; Kehagias E; Karnabatidis D; Brountzos E; Tsetis D
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1481-1487. PubMed ID: 29992345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal cut-off value of preprocedural geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease.
    Yamaguchi T; Ueshima D; Utsunomiya M; Matsui A; Miyazaki T; Matsumoto M; Shimura T; Murata N; Komatsu Y; Tobita K; Fujimoto Y; Kodama T; Suzuki K; Anzai H; Jujo K; Higashitani M
    J Cardiol; 2021 Feb; 77(2):109-115. PubMed ID: 32888832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.
    Raghunathan A; Rapp JH; Littooy F; Santilli S; Krupski WC; Ward HB; Thottapurathu L; Moritz T; McFalls EO;
    J Vasc Surg; 2006 Jun; 43(6):1175-82. PubMed ID: 16765234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Schwartz GG; Steg PG; Szarek M; Bittner VA; Diaz R; Goodman SG; Kim YU; Jukema JW; Pordy R; Roe MT; White HD; Bhatt DL;
    Circulation; 2020 May; 141(20):1608-1617. PubMed ID: 32223446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.